Evidence map›Paper›PMID 35886318›Full record

Observational studyInternational journal of environmental research and public health2022

SarQoL Questionnaire in Community-Dwelling Older Adults under EWGSOP2 Sarcopenia Diagnosis Algorithm: A New Screening Method?

Carlos Guillamón-Escudero, Angela Diago-Galmés, David Zuazua Rico, Alba Maestro-González, Jose M Tenías-Burillo, Jose M Soriano, Julio J Fernández-Garrido

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Frontiers in genetics · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Carlos Guillamón-EscuderoHospital General Universitari de Castelló, 12004 Castelló de la Plana, Spain.ORCID 0000-0002-5127-6010
Angela Diago-GalmésHospital Universitario de La Plana, 12540 Villarreal, Spain.ORCID 0000-0002-2954-6993
David Zuazua RicoDepartment of Medicine, Nursing Area, University of Oviedo, 33006 Oviedo, Spain.ORCID 0000-0002-5945-5945
Alba Maestro-GonzálezDepartment of Medicine, Nursing Area, University of Oviedo, 33006 Oviedo, Spain.ORCID 0000-0002-1588-9362
Jose M Tenías-BurilloDepartment of Preventive Medicine, Hospital Pare Jofré, 46017 Valencia, Spain.ORCID 0000-0002-8079-8491
Jose M SorianoFood & Health Lab, Institute of Materials Science, University of Valencia, 46980 Valencia, Spain.ORCID 0000-0003-2846-1311
Julio J Fernández-GarridoDepartment of Nursing, Faculty of Nursing and Podiatry, University of Valencia, 46001 Valencia, Spain.ORCID 0000-0001-5195-5227
Universidad de Oviedo · ESUniversitat de València · ESHospital General Universitari de Castelló · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article is an observational and cross-sectional study that related the result obtained in the questionnaire for the evaluation of quality of life related to muscle mass (SarQoL) and the prevalence of sarcopenic pathology measured under the EWGSOP2 algorithm. Participants were 202 community-dwelling older adults living in Valencia, Spain. The prevalence of sarcopenia in men was 28.9%, while in women it was 26.2%. In the case of the SarQoL questionnaire, the mean score obtained for men was 75.5 and 72.6 for women, showing significant differences in both sexes between the results obtained by the group with and without sarcopenia. After the exhaustive data analysis, a high discriminative capacity for sarcopenic disease was found in the SarQoL questionnaire total score and in domains 2 (locomotion), 4 (functionality) and 5 (activities of daily living). In accordance with the existing controversy regarding the use of SARC-F as a screening method for sarcopenia, the authors pointed out the capacity of domain 2 (locomotion) in isolation as a possible screening method for this disease, exposing a high risk of suffering sarcopenia when scores in this domain were below 60 points. Further research is needed to develop new lines of research as these showed in this work, as well as new and easily applicable screening methods for sarcopenia in clinical practice, that allow a rapid detection of this disease in the community.

Indexed as

SarcopeniaActivities of Daily LivingAgedAlgorithmsCross-Sectional StudiesFemaleGeriatric AssessmentHumansIndependent LivingMaleQuality of LifeSurveys and Questionnairesmuscle strengtholder adultsolder peoplequality of lifesarcopeniaSarQoL

Identifiers

PMID35886318
PMCPMC9324056
OpenAlexW4285022514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.